Form 8-K · Current report
Insulet Corporation 8-K, filed Sep 16, 2026
- Filed
- CIK
- 0001145197
- Accession no.
- 0001145197-26-000177
Summary
Insulet Corporation's Talent and Compensation Committee approved a Nonqualified Deferred Compensation Plan on September 14, 2026, effective January 1, 2027, allowing a select group of management and highly compensated employees, including named executive officers, to defer up to 60% of cash compensation. Participant cash deferrals vest fully, while company matching, nonelective and discretionary contributions generally vest on a two-year cliff and fully upon a change in control.
Key points
- The plan is an unfunded "top hat" arrangement intended to comply with ERISA and Section 409A of the Internal Revenue Code.
- Equity awards may not be deferred under the plan.
- Payments follow a participant-specified date or separation from service, death or disability, with separation payments delayed to the first payroll date of the seventh month after separation.
- All accounts would be paid within 30 days following a change in control, and the committee may terminate or amend the plan at its discretion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Adoption of Nonqualified Deferred Compensation Plan On September 14, 2026, the Talent and Compensation Committee (the "Committee") of the Board of Directors (the "Board") of Insulet Corporation (the "Company") approved and adopted the Insulet Nonqualified Deferred Compensation Plan (the "Plan"), with such Plan to be effective on January 1, 2027. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.